Share

New antibiotic treats skin infections faster

accreditation
iStock

A short course of treatment with a newer antibiotic called tedizolid works as well against bacterial skin infections as longer treatment with the antibiotic linezolid, a new study finds.

"These infections, which include cellulitis and other wound infections, can be life threatening," noted one expert not connected to the study, Dr Michele Green, a dermatologist at Lenox Hill Hospital, in New York City. "Because so many of these infections have become antibiotic-resistant, the development of a novel antibiotic which is effective is very important," she added.

The new phase 3 clinical trial included 667 adult patients in North America, Latin America and Europe who received either 200 milligram pills once a day of tedizolid phosphate for six days, or 600 mg of linezolid every 12 hours for 10 days.

The drugs showed similar levels of effectiveness after two to three days and after 11 days, according to the study.

Side effects, mostly mild or moderate, occurred in nearly 41% of patients taking tedizolid and about 43% of those taking linezolid. Rates of serious side effects were low and similar in both groups, according to a journal news release.

The study was led by Dr Philippe Prokocimer, of Trius Therapeutics Inc., San Diego, which makes tedizolid and funded the study.

'A great starting point'

According to Green, the study suggests tedizolid is "a reasonable alternative" to the older drug, especially for infections with MRSA (methicillin-resistant Staphylococcus aureus), "which is a growing problem, due to antibiotic resistance and the continued use of prolonged antibiotics."

Another expert agreed. Dr Scott Gorenstein is an expert in wound healing therapies at Winthrop-University Hospital in Mineola, NY. He said it is important to find shorter-course antibiotic therapies to help reduce antibiotic resistance and the risk for complications.

Gorenstein, who is also clinical director of the hospital's Hyperbaric Medicine Program, called the study "a great starting point" for further research to confirm these findings.

More information

MedlinePlus has more about skin infections.

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE